- Home
- MDGL vs OTEX Comparison
MDGL vs OTEX Comparison
Compare MDGL & OTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- OTEX
- Stock Information
- Founded
- MDGL 2011
- OTEX 1991
- Country
- MDGL United States
- OTEX Canada
- Employees
- MDGL N/A
- OTEX N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- OTEX EDP Services
- Sector
- MDGL Health Care
- OTEX Technology
- Exchange
- MDGL Nasdaq
- OTEX Nasdaq
- Market Cap
- MDGL 7.1B
- OTEX 7.8B
- IPO Year
- MDGL N/A
- OTEX 1998
- Fundamental
- Price
- MDGL $336.23
- OTEX $26.83
- Analyst Decision
- MDGL Buy
- OTEX Hold
- Analyst Count
- MDGL 14
- OTEX 8
- Target Price
- MDGL $351.67
- OTEX $32.71
- AVG Volume (30 Days)
- MDGL 357.1K
- OTEX 815.0K
- Earning Date
- MDGL 02-26-2025
- OTEX 02-06-2025
- Dividend Yield
- MDGL N/A
- OTEX 3.91%
- EPS Growth
- MDGL N/A
- OTEX 421.00
- EPS
- MDGL N/A
- OTEX 2.45
- Revenue
- MDGL $76,813,000.00
- OTEX $5,412,785,000.00
- Revenue This Year
- MDGL N/A
- OTEX N/A
- Revenue Next Year
- MDGL $195.95
- OTEX $2.70
- P/E Ratio
- MDGL N/A
- OTEX $10.95
- Revenue Growth
- MDGL N/A
- OTEX N/A
- 52 Week Low
- MDGL $189.00
- OTEX $26.81
- 52 Week High
- MDGL $368.29
- OTEX $40.55
- Technical
- Relative Strength Index (RSI)
- MDGL 52.41
- OTEX 36.92
- Support Level
- MDGL $334.13
- OTEX $27.83
- Resistance Level
- MDGL $354.49
- OTEX $28.80
- Average True Range (ATR)
- MDGL 13.20
- OTEX 0.95
- MACD
- MDGL 0.16
- OTEX -0.23
- Stochastic Oscillator
- MDGL 43.12
- OTEX 0.40
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
About OTEX Open Text Corporation
Open Text Corp is engaged in the design, development, marketing, and sale of Information Management software and solutions. Its software allows clients to archive, aggregate, retrieve, and search unstructured information (such as documents, e-mail, and presentations). Its platform and services provide secure and scalable solutions for enterprises, SMBs, governments, and consumers around the world. The company's solutions are marketed and delivered on the OpenText Cloud Platform, which is a comprehensive Information Management platform consisting of six business clouds; Content Cloud, Cybersecurity Cloud, Application Automation Cloud, Business Network Cloud, IT Operations Management Cloud, and Analytics Cloud. Geographically, it derives maximum revenue from the United States.